You are here: / HB4 Wheat
thumbnail
, ,

Broadcast Version – U.S. Wheat Associates Statement on USDA Deregulation of HB4 Drought-Tolerant Trait in Wheat

ANNOUNCER:

The U.S. Department of Agriculture announced it will deregulate the HB4 drought tolerant trade in wheat. Farmer leaders of U.S. Wheat Associates commended USDA’s thorough, science-based process and expressed confidence in the trait’s potential to deliver significant benefits for both producers and consumers. Oklahoma wheat grower and U.S. Wheat Associates past chairman Michael Peters has visited Bioceres Crop Science test plots in South America.

As Peters shares here, he was impressed with the research and is hopeful of what the trade could mean for wheat farmers, especially those in drought prone areas.

MICHAEL PETERS (00:39)

“As a wheat farmer in the Southern Plains, I definitely see the HB4 trait being a tool that I can have in my toolbox for those years that there is some drought, especially in the periods when the wheat is coming out of winter dormancy, when it really needs that moisture, or when it’s going into its reproductive phase.

“Having the opportunity to visit Bioceres test plots in Argentina, I was impressed with the quality of the wheat that was being grown. Being able to see how the technology was being used, and the possibility of how it could be used on our farmland in the U.S., I think it’s definitely a tool that every farmer would like to have — you know, for those periods that it really is dry weather so that we can continue to be a supplier of good quality grain”

ANNOUNCER (01:26)

U.S. Wheat Associates’ Policy Team continues to follow the HB4 issue closely. Director of Trade Policy Peter Laudeman, who also visited Bioceres test plots in South America, shares with us that there is still a lot of ground to cover with the technology, and that U.S. Wheat will stay actively engaged in the process on behalf of farmers and international customers.

PETER LAUDEMAN (01:48)

“We’re really excited to see this announcement come out of USDA that just follows the basic science-based regulatory system that we know comes out of the Part 340 revision of regulations. as Bioceres continues to move forward, there’s a distinction between this regulatory approval and then the number of steps that they’ll need to move forward with to make sure they have a commercial plan to bring this product to market.

“We’re looking forward to continuing in that dialog with Bioceres and will keep all of our board members and the Wheat Breeding Innovation Committee members apprised of those conversations.

“One of the most important pieces of discussion we’ve had with Bioceres over time is our Wheat Industry Joint Principles for Biotechnology Commercialization, which is kind of a big mouthful for the kind of document that we share with the National Association of Wheat Growers to really outline how U.S. Wheat is supportive of bringing technology to the market, and to make sure we do it in the right way. To make sure that customers have the choices they want in the marketplace, but also that growers have access to great new science-based technologies, as well.

“Certainly, this is the first time we’ve seen this from wheat. So, it’s a new experience. but, as we’re looking at a timeline, we probably think somewhere in the 3- to 5-year range.”

OUT 03:00

More information about Bioceres, HB4®, and U.S. wheat organization positions on transgenic wheat commercialization is available at:

/by
thumbnail
, ,

U.S. Wheat Associates Statement on USDA Approval of HB4® Drought-Tolerant Wheat Trait

U.S. Wheat Associates (USW) commends the U.S. Department of Agriculture (USDA) for its thorough, science-based process resulting in the deregulation of the HB4® drought-tolerant trait from Bioceres Crop Solutions announced on August 27, 2024. The farmer leaders of USW are confident that the HB4® trait has the potential to deliver significant producer and consumer benefits.

Although USDA’s ruling clears the regulatory pathway for cultivation of HB4® wheat in the United States, there are several additional steps needed before those benefits are realized and HB4® is grown commercially in the United States. These include the need to conduct closed-system field trials prior to commercialization. USW will continue monitoring Bioceres’ commercialization plans to ensure careful stewardship and alignment with the “Wheat Industry Principles for Biotechnology Commercialization” developed jointly with the National Association of Wheat Growers (NAWG).

“Wherever wheat is grown in the world, drought takes its toll on yields and quality, so an innovation like HB4 holds a lot of interest for growers like me,” said USW Past Chairman and Okarche, Okla., wheat grower Michael Peters. “With global demand for wheat hitting new records almost every year, there is concern about variable production.

Photo of Michael Peters on his farm in Oklahoma.

Michael Peters on his farm near Okarche, Okla. Photo By Steve Gooch, The Oklahoman.

A drought-tolerant trait offers more stable, sustainable production. At the same time, it is important that customers who have specific purchase preferences understand the industry supports their ability to purchase the type of wheat they want. That remains our policy after more than 16 years.”

In line with the principles for commercialization, USW and NAWG support for HB4® and any transgenic wheat commercialization is linked to the technology company receiving regulatory approval in major importing countries that represent at least five percent of average U.S. wheat export volume.

In addition to the U.S. Food and Drug Administration accepting the safety of the HB4® trait in 2022, Bioceres has received regulatory approval for food and feed use in Nigeria, Brazil, Colombia, Indonesia, and South Africa, and has applied for approval in several other countries. Farmers are currently growing wheat with the HB4® trait in Argentina and Brazil. Bioceres also plans field trials in Australia with the intent to gain regulatory approval for cultivation there.

“A drought-tolerant trait offers more stable and sustainable production. At the same time, it is important that customers who may be concerned about introducing transgenic wheat into U.S. supplies understand the industry supports their ability to purchase the type of wheat they want. That remains our policy after more than 16 years.” – Michael Peters

“Our organization has established a productive dialogue with Bioceres, and we appreciate that the company understands the importance of our joint wheat industry principles,” said USW Director of Trade Policy Peter Laudeman. “I have travelled with growers to Argentina to see HB4 wheat in the field and they were impressed by its performance. We believe the trait represents good science with positive potential to improve food security in a more sustainable way.”

Peter Laudeman Thumbnail Portrait

Peter Laudeman, USW Director of Trade Policy.

Laudeman noted that beyond the announcement of the competed regulatory review, it will still take years for Bioceres to complete the additional steps needed to successfully commercialize wheat with the HB4® trait in the United States.

“There is still a lot of ground to cover with this technology and our organization will stay actively engaged in the process on behalf of our farmers and overseas customers,” Laudeman said, “We appreciate the commitment that Bioceres is making to working with its wheat industry partners to ensure robust stewardship of this technology prior to commercial release.”

More information about Bioceres, HB4®, and U.S. wheat organization positions on transgenic wheat commercialization is available at:

A broadcast version of this statement is available here.

/by
thumbnail
,

Joint Statement on FDA’s Drought Tolerant HB4 Wheat Safety Conclusion

This is a Joint Statement by U.S. Wheat Associates (USW) and the National Association of Wheat Growers (NAWG) on the U.S. Food and Drug Administration (FDA) conclusion that it has no further questions regarding the safety of drought tolerant HB4 wheat developed by Bioceres Crop Solutions Corp.

The finding by the FDA is not an approval for this or any other transgenic wheat to be planted for commercial sale in the United States. To date, the HB4 wheat has been approved for commercial production within a closed system in Argentina only. The trait has been approved for human consumption by regulators in Brazil in the form of flour, and in Australia, New Zealand and now in the United States. Bioceres recently announced it will seek approval to plant HB4 wheat in Australia, but it has not announced plans to commercialize the trait in the United States.

With global demand for wheat increasing every year the need to produce more wheat in sustainable ways is clear. Drought had already reduced world wheat supplies and pushed prices higher before the invasion of Ukraine cut off supplies from the world’s fifth largest wheat exporting nation. A trait such as drought tolerance in wheat could help wheat growers in increasingly arid regions be more productive and ease food security concerns. Bioceres says the HB4 drought-tolerance technology has been shown to increase wheat yields by an average of 20% in water-limited conditions.

The U.S. wheat industry recognizes the benefits and value that can be created through the prudent application of modern biotechnology. USW and NAWG are guided by jointly approved “Wheat Industry Principles for Biotechnology Commercialization,” which lay out specific steps expected from plant breeding companies if they wish to commercialize transgenic wheat in the United States.

In addition, USW and NAWG support the ability of domestic and overseas customers to make purchases based on their preferences for specific wheat traits, classes, qualities and characteristics.

/by

Think Farm Export Programs Don’t Matter? Think Again.

GET THE REST OF THE STORY

DTN Wheat Detail
DTN Corn Detail

2008-2013 U.S. Wheat Associates. All Rights Reserved
Privacy Policy | Non-Discrimination Statement